A Commonwealth Fund study has revealing findings about PBMs’ use of rebates and impact on drug prices.
While pharmacy benefit managers were grilled about insulin prices at Congressional hearings last week, some PBMs, insurers and pharma makers are already lowering insulin costs.
Walgreens is partnering with VillageMD to create primary care clinics in Texas
FDA cleared Dovato (ViiV Healthcare), the first 2-drug regimen to treat HIV-1 in adults with no antiretroviral treatment history.
Metastatic breast cancer drug expands treatment to men.
FDA fast-tracks biosimiliar insulin products to elevate competition.
FDA approved 2 new multiple sclerosis drugs. Here's what you should know about them.
Several companies are recalling products due to contamination from substances such as carcinogens and glass—here’s what you should know.
Postpartum drug is a game changer, but can women afford it?
FDA approved a new subcutaneous injection to treat a certain type of early breast cancer.